The fruitful endeavors of the life sciences industry are impossible to miss. The year 2021 begins with two Covid-19 vaccines developed, tested and approved for use in just under a year along with multiple treatments, diagnostics and other medical technology.
The Department of Health and Human Services has issued several waivers for Texas hospitals reeling from the devastating winter storm that has gripped the state. These waivers provide flexibility in complying with HIPAA rules and other federal regulations. Texans are
Dive Brief: The Trump administration on Friday finalized a rule requiring HHS to review existing regulations, with some exceptions, every 10 years based on their real-world impact. If not reviewed and approved in time, old rules would automatically expire. When
The world hit a few more pandemic milestones this week with the distribution of the coronavirus vaccines developed by Moderna and by Pfizer and BioNTech; the advancement of trials studying other experimental shots; and the approval or authorization of coronavirus
1.Soma-Pillay, P., Nelson-Piercy, C., Tolppanen, H. & Mebazaa, A. Physiological changes in pregnancy. Cardiovasc. J. Afr. 27, 89–94 (2016).PubMed PubMed Central Article Google Scholar 2.Arck, P. C. & Hecher, K. Fetomaternal immune cross-talk and its consequences for maternal and offspring’s
GE Healthcare, Medtronic and Philips are among the big medtechs investing in artificial intelligence and machine learning, technologies they contend hold potential for better diagnosing, managing and treating a wide variety of diseases and health conditions. While medtechs are only
For digital therapeutics companies, the FDA has often been viewed as the gatekeeper to getting products to the patients. However, today the conversation around efficacy and research is branching beyond just what ticks the FDA boxes, into what kinds of
Fitbit’s new electrocardiogram app has officially received regulatory clearance in the U.S. and European Union for its latest smartwatch, the Fitbit Sense, to monitor heart rhythm and detect atrial fibrillation. Now that the app has 510(k) clearance from the U.S.
About the authors: Andrew Dudum is the CEO and founder of Hims & Hers, a consumer-facing digital health company offering telehealth services. Joel White is executive director of the Health Innovation Alliance, a coalition of health and technology leaders who support
While some of the more obvious barriers to digital therapeutics adoption in Europe have come crashing down recently, adoption is still hampered by cultural momentum. That was the conclusion of a group of digital therapeutics stakeholders who presented at HIMSS